REGENEREX PHARMA, INC. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Regenerex Pharma, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
  • Regenerex Pharma, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$258K, a 90.7% increase year-over-year.
  • Regenerex Pharma, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$1.03M, a 65.6% increase year-over-year.
  • Regenerex Pharma, Inc. annual Operating Income (Loss) for 2023 was -$3.47M, a 3504% decline from 2022.
  • Regenerex Pharma, Inc. annual Operating Income (Loss) for 2022 was -$96.2K, a 23.8% increase from 2021.
  • Regenerex Pharma, Inc. annual Operating Income (Loss) for 2021 was -$126K, a 191% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$1.03M -$258K +$2.53M +90.7% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 -$3.56M -$254K -$94.1K -58.8% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-07
Q1 2024 -$3.47M -$280K -$252K -891% Jan 1, 2024 Mar 31, 2024 10-K 2024-06-24
Q4 2023 -$3.21M -$239K -$210K -723% Oct 1, 2023 Dec 31, 2023 10-Q 2024-02-05
Q3 2023 -$3M -$2.79M -$2.76M -12855% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 -$239K -$160K -$143K -827% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-07
Q1 2023 -$96.2K -$28.3K +$3.25K +10.3% Jan 1, 2023 Mar 31, 2023 10-K 2024-06-24
Q4 2022 -$99.4K -$29.1K +$32.9K +53% Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-05
Q3 2022 -$132K -$21.5K -$431 -2.05% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 -$132K -$17.3K -$5.6K -47.9% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$126K -$31.5K -$24.4K -344% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-09
Q4 2021 -$102K -$62K -$47.7K -335% Oct 1, 2021 Dec 31, 2021 10-Q 2023-01-24
Q3 2021 -$54.1K -$21.1K -$9.12K -76.2% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$45K -$11.7K -$1.59K -15.7% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$43.4K -$7.1K +$14.5K +67.2% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-28
Q4 2020 -$57.9K -$14.3K -$1.62K -12.9% Oct 1, 2020 Dec 31, 2020 10-Q/A 2022-02-03
Q3 2020 -$56.3K -$12K -$335 -2.88% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-01
Q2 2020 -$56K -$10.1K +$21K +67.5% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 -$77K -$21.6K -$5.58K -34.7% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-23
Q4 2019 -$71.4K -$12.6K +$39.7K +75.9% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 -$111K -$11.6K -$6.8K -141% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-10
Q2 2019 -$104K -$31.1K -$12.6K -67.6% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 -$91.7K -$16.1K -$2.11K -15.1% Jan 1, 2019 Mar 31, 2019 10-K/A 2020-08-11
Q4 2018 -$89.6K -$52.3K -$42K -410% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-10
Q3 2018 -$47.6K -$4.82K +$3.32K +40.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-10-30
Q2 2018 -$50.9K -$18.6K -$1.47K -8.57% Apr 1, 2018 Jun 30, 2018 10-Q/A 2019-07-29
Q1 2018 -$49.5K -$14K -$5.81K -71.3% Jan 1, 2018 Mar 31, 2018 10-K 2019-06-24
Q4 2017 -$43.6K -$10.3K -$8.04K -363% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-04
Q3 2017 -$35.6K -$8.14K Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 -$17.1K Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-09
Q1 2017 -$8.14K +$12.9K +61.2% Jan 1, 2017 Mar 31, 2017 10-Q 2017-11-07
Q4 2016 -$2.21K Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-08
Q1 2016 -$21K Jan 1, 2016 Mar 31, 2016 10-Q 2017-11-07
Q3 2011 -$16K +$1.8K +10.1% Jun 1, 2011 Aug 31, 2011 10-Q 2011-10-13
Q3 2010 -$17.8K Jun 1, 2010 Aug 31, 2010 10-Q 2011-10-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.